Skip to content
M

Mohammed Abdullah Alahmadi

0000-0001-6552-8795

Publications (3)

Efficacy and Safety of Lebrikizumab in Atopic Dermatitis: A Systematic Review and Meta-analysis

Mohammed Abdullah Alahmadi, Khadeeja Ali Hamzah, Eathar Haidar Aljubori, Dalia Dhia Hadi, Marwa Mohammed Saleh Tuke, Mohamed Ellebedy, Juman Alammar, Ghadir Ali Alkhfash & Haydar Raheem Hmoud Al-Saaidy · Journal of Pharmaceutical Research International · 2024

Background: Atopic Dermatitis (AD) is a long-lasting dermatological condition that leads to skin irritation and inflammation. In cases of severe cases of AD biological therapy may be warranted. In this systematic review and meta-analysis, we aim to assess the efficacy and safety...

Open access Research Article 10.9734/jpri/2024/v36i117610

A Holistic Review of Rosacea and Its Association with Cardiovascular Diseases

Aymen Alharbi, Mohammed Abdullah Alahmadi, Sarah Mohammad Radwan, Abdulelah Nawaf Alraddadi, Esraa A. Shaheen & Roaa Abdulrahman Allehyani · Journal of Pharmaceutical Research International · 2024

Rosacea is a chronic inflammatory dermatological condition with different clinical phenotypes, usually diagnosed clinically and treated with systemic and topical medications. Rosacea is one of the skin conditions that is often believed to just have cutaneous manifestation, but it...

Open access Research Article 10.9734/jpri/2024/v36i37505

Challenges and Outcomes of Chronic Dialysis in Children: A Narrative Review

Bader Osama Sager, Fahad Beshr Almughirah, Ibrahim Abdullah Alhariqi, Aseel Abdulhafez Alharbi, Mohammed Abdullah Alahmadi & Faris M Elmahdi · Journal of Pharmaceutical Research International · 2024

Chronic dialysis is a life-saving treatment for children with end-stage renal disease (ESRD). However, it comes with difficult challenges, cardiovascular ones being the most significant and fatal. Chronic kidney disease-mineral bone disorder (CKD-MBD) is also a common complicatio...

Open access Research Article 10.9734/jpri/2024/v36i57512